209 results
8-K
EX-99.1
IMNN
Imunon Inc
28 Mar 24
IMUNON Reports 2023 Financial Results and Provides Business Update
8:05am
in disease progression or death in the treatment arm compared with the control arm, and preliminary OS data showed an approximate nine-month … , hospitalization or death.
Submitted an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) in the first quarter of 2024
8-K
EX-3.1
IMNN
Imunon Inc
18 Mar 24
Amendments to Articles of Incorporation or Bylaws
8:00am
bearing a later date with the secretary of the corporation.
A proxy is not revoked by the death or incapacity of the maker unless, before the vote … is counted, written notice of such death or incapacity is received by the corporation.
2.14 INSPECTORS OF ELECTION. In conjunction with any meeting
8-K
EX-99.1
l8x19n2rucy
10 Aug 23
IMUNON Reports Second Quarter 2023 Financial Results and Provides Business Update
8:09am
8-K
EX-10.1
5l7phs
15 Jun 23
Departure of Directors or Certain Officers
4:43pm
8-K
EX-99.1
9dz2i24
11 May 23
IMUNON Reports First Quarter 2023 Financial Results and Provides Business Update
8:05am
8-K
EX-3.3
uyshh9lhu5yrc9etyc0
19 Sep 22
New name reflects the evolution of the Company’s business focus and its commitment to immunotherapies and vaccines
4:52pm
8-K
EX-10.2
9spb ewfb
19 Jul 22
Celsion Appoints Dr. Corinne Le Goff as President and Chief Executive Officer
9:19am